To this extent, we present data that supports the premise that IRF5 isoforms have differential abilities to regulate proinflammatory cytokines associated with SLE pathogenesis (Fig. 8) [19], [40]. This evidence concerns the gene IRF5 and systemic lupus erythematosus.